It was previously reported that CYP2B6 mRNA expression was decreased in hepatocellular carcinoma (HCC), and contrary, significantly increased in HBV and alcoholic cirrhosis, as well as in NAFLD [8, 22]. This evidence concerns the gene CYP2B6 and hepatocellular carcinoma.